It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Objective
To assess the quality of the therapeutic approach in Specialized Headache Units in Spain.
Methods
An observational (prospective) study was conducted. Anonymized data of 313 consecutive patients during a defined period of time were analyzed and a comparison of performance in 13 consensual quality indicators between Specialized Headache Units and neurology consultations was calculated. Specialized Units and neurology consultations represented the type of provision that Spaniards receive in hospitals.
Results
The consensus benchmark standard was reached for 8/13 (61%) indicators. Specialized Headache Units performed better in the indicators, specifically in relation to accessibility, equity, safety, and patient satisfaction. Patients attended in Specialized Headache Units had more complex conditions.
Conclusion
Although there is variability among Specialized Headache Units, the overall quality was generally better than in traditional neurology consultations in Spain.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Hospital Universitari Vall d’Hebron, Headache Unit, Neurology Department, Barcelona, Spain (GRID:grid.411083.f) (ISNI:0000 0001 0675 8654); Vall d’Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Headache Research Group, Barcelona, Spain (GRID:grid.7080.f)
2 Miguel Hernández University, Calitè Research Group, Elche, Spain (GRID:grid.26811.3c) (ISNI:0000 0001 0586 4893)
3 Marqués de Valdecilla Hospital, Santander, Spain (GRID:grid.26811.3c); Valdecilla Biomedical Research Institute (IDIVAL), Santander, Spain (GRID:grid.484299.a)
4 Cádiz University, Cádiz, Spain (GRID:grid.7759.c) (ISNI:0000000103580096)
5 University Hospital of Valladolid, Headache Unit, Neurology Department, Valladolid, Spain (GRID:grid.411057.6) (ISNI:0000 0000 9274 367X); Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain (GRID:grid.452531.4)
6 University Hospital of Getafe, Neurology Department, Getafe, Spain (GRID:grid.411244.6) (ISNI:0000 0000 9691 6072)
7 San Carlos Hospital, Headache Unit, Neurology Department, Madrid, Spain (GRID:grid.411244.6)
8 University Hospital of Fuenlabrada, Neurology Department, Madrid, Spain (GRID:grid.411171.3) (ISNI:0000 0004 0425 3881)
9 University Hospital of Albacete, Neurology Department, Albacete, Spain (GRID:grid.411171.3)
10 Virgen de la Arrixaca University Hospital, Neurology Department, Murcia, Spain (GRID:grid.411372.2) (ISNI:0000 0001 0534 3000)
11 Alicante-Sant Joan Health District, Alicante, Spain (GRID:grid.411372.2); Health Services Research in Chronic Illnesses Network, REDISSEC, Alicante, Spain (GRID:grid.411372.2)